T1	Participants 51 98	infants with chronic bronchopulmonary dysplasia
T2	Participants 113 152	double-blind crossover sequential trial
T3	Participants 324 373	ten infants with bronchopulmonary dysplasia (BPD)
T4	Participants 1400 1448	infants with chronic bronchopulmonary dysplasia;
